Skip to main content

Voltron Therapeutics

New York, United States

Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.

$5.9M raised
Aug 2023
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Voltron Therapeutics

How much funding has Voltron Therapeutics raised?
Voltron Therapeutics has raised $5.9M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
Who are Voltron Therapeutics's investors?
Voltron Therapeutics's investors include U.S. Department of War.
Where is Voltron Therapeutics headquartered?
Voltron Therapeutics is headquartered in New York, United States.
What does Voltron Therapeutics do?
Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
What stage is Voltron Therapeutics at?
Voltron Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Voltron Therapeutics — Funding & Investors." VCBacked, August 17, 2023, https://www.vcbacked.co/company/voltron-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Voltron Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/voltron-therapeutics
Wikipedia (cite web)
{{cite web |title=Voltron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/voltron-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .